Background: Brain tumors account for 2%-3% of all malignant neoplasms and 85%-90% of all primary tumors of the central nervous system with the 5-year survival rate of 35%. Additional biomarkers could help refine the molecular profile of brain tumors and prognosis of the disease.
Aim: To study differential expression patterns of the MRPS18 family genes in tumor tissue and the peripheral blood of patients with brain tumors of various types.